Hormel Foods reports higher sales of $2.96 billion
Hormel Foods (NYSE:HRL) reported third quarter fiscal 2026 net sales of $2.96 billion, compared with $3.03 billion in the prior-year period, while organic net sales declined 2%.
Todas as matérias desta seção, das mais recentes às mais antigas — página 73 de 371.
Hormel Foods (NYSE:HRL) reported third quarter fiscal 2026 net sales of $2.96 billion, compared with $3.03 billion in the prior-year period, while organic net sales declined 2%.
Bilibili (NASDAQ:BILI) reported second quarter 2026 total net revenues of RMB7.94 billion, up 8% year over year, as advertising revenue increased 28% to RMB3.13 billion.
Lotus Technology (NASDAQ:LOT) reported first half 2026 revenue of $268 million, up 23% year over year, as vehicle deliveries increased 39% to 3,904 units following the launch of the PHEV model Eletre X.
Canadian Solar (NASDAQ:CSIQ) reported second quarter 2026 net revenue of $1.2 billion, up 12% from the previous quarter but down 29% year over year, while battery energy storage shipments increased to 3.7 GWh.
Brent crude futures fell $1.36, or 1.55%, to $86.48 a barrel, while West Texas Intermediate (WTI) crude futures declined $1.40, or 1.7%, to $80.83 as markets reacted to expectations of reduced supply disruptions.
Standard Nuclear (NYSE:STDN) reported second quarter 2026 revenue of $4.7 million, up from $0.6 million in the prior-year period, while total contract backlog later increased to $576.9 million following new customer agreements.
Marvell Technology (NASDAQ:MRVL) reported record fiscal 2027 second-quarter net revenue of $2.739 billion, up 37% year over year and $39 million above the midpoint of its previous guidance.
Mesoblast (NASDAQ:MESO) reported FY2026 total revenue of $120.3 million, up from $17.2 million a year earlier, as the company recorded its first full U.S. commercial year of Ryoncil sales.
Materialise NV (NASDAQ:MTLS) reported second quarter 2026 revenue of EUR70.1 million, up 8.1% year over year, while adjusted EBITDA increased to EUR9.6 million from EUR8.3 million.
CMB.TECH (NYSE:CMBT) reported unaudited second quarter 2026 revenue of USD703.9 million, compared with USD387.8 million in the same period last year, while profit for the period reached USD364.4 million.
AbbVie (NYSE:ABBV) submitted a regulatory application to the European Medicines Agency for subcutaneous SKYRIZI (risankizumab) induction treatment in adults with moderately to severely active Crohn’s disease.
Amgen (NASDAQ:AMGN) and AstraZeneca (NYSE:AZN) reported positive Phase 3 results from the CROSSING trial of TEZSPIRE (tezepelumab-ekko), with the study meeting both primary endpoints in 368 patients with symptomatic eosinophilic esophagitis.
Gaotu Techedu (NYSE:GOTU) reported second quarter 2026 net revenues of RMB1,670.1 million, up 20.2% year over year, as gross billings reached RMB2,689.1 million and gross margin improved to 66.5%.
NVIDIA (NASDAQ:NVDA) reported second quarter fiscal 2027 revenue of $96.2 billion, up 106% year over year, as Data Center revenue reached $89 billion and drove the company’s latest quarterly results.
CrowdStrike (NASDAQ:CRWD) reported second-quarter fiscal 2027 revenue of $1.47 billion, up 26% year over year, driven by subscription revenue growth and increased recurring revenue.
Salesforce (NYSE:CRM) reported second-quarter fiscal 2027 revenue of $11.3 billion, up 11% year over year and in constant currency for the quarter ended July 31, 2026.
Meta (NASDAQ:META) agreed to pay up to $18 billion to settle claims from 29 U.S. states alleging that its platforms contributed to risks for children and collected data from young users without proper parental knowledge.
Perion (NASDAQ:PERI) agreed to acquire PRN, an in-store retail media company, in a transaction valued at up to $12 million in cash to expand its presence in the retail media market.
Bitdeer (NASDAQ:BTDR) announced a 16-year AI and high-performance computing data center lease for its Tydal, Norway campus with a Volta subsidiary, covering 121 IT MW configured with NVIDIA GPUs.
Daiichi Sankyo and AstraZeneca (NYSE:AZN) dosed the first patient in the phase 3 TROPION-Urothelial04 trial evaluating Datroway plus rilvegostomig or Datroway monotherapy in patients with high-risk muscle invasive urothelial cancer.
Sound Group (NASDAQ:SOGP) reported unaudited first-half 2026 net revenues of RMB1,690.6 million, or US$249.2 million, up 25% year over year, with net income increasing to RMB120.5 million.
Photronics (NASDAQ:PLAB) reported a 2.7% year-over-year revenue increase to $216.0 million for the third quarter of 2026.
Dycom (NYSE:DY) reported record fiscal second-quarter 2027 contract revenues of $2.006 billion, up 45.6% year over year, including 16.7% organic growth.
Williams-Sonoma (NYSE:WSM) reported second-quarter 2026 comparable brand revenue growth of 6.2%, with GAAP operating income reaching $449 million and operating margin of 22.9%.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade